Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-01

Clinical Trial Update: Curcumin in Pediatric Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 trial of curcumin in pediatric ulcerative colitis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)

Snippet

Sponsor: Schneider Children's Medical Center, Israel | Conditions: Ulcerative Colitis | Phase 3 | Status: WITHDRAWN